With alopecia areata in the headlines, Clinical Trials Arena looks at a potential shake-up in its drug options and an ...

The event will discuss data from emerging OX40/OX40L inhibitors, including Inmagene’s IMG-007 - the only clinical-stage non-depleting anti-OX40 mAb. A live question and answer session will follow the ...

There are many forms or types of alopecia, each presenting with varying amounts of hair loss. Here’s how they appear, how ...

However, there are some forms of treatment that aim to manage symptoms and promote hair regrowth. 1. Corticosteroid creams: It is commonly used to treat the most common form of alopecia, alopecia ...

Dr. Crystal Aguh’s research shows promising results for reversing “devastating” hair loss. Alopecia, a general term used to ...

Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

Arash Mostaghimi, MD, MPA, MPH, director of the inpatient dermatology consult service at Brigham & Women's Hospital, discusses the utility of deuruxolitinib for treating moderate to severe alopecia ...

Aquestive Therapeutics (AQST – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

“At this year’s European Dermatology Congress, we will accelerate discussions on our alopecia areata treatment alongside our atopic dermatitis drug, engaging global experts to expedite ...

It’s normal to lose about 50 to 100 hairs a day. But it can be upsetting when you notice more hair loss than this, bald ...